Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
targomirs (1 trial)
Carcinoma, Non-Small-Cell Lung (Phase 1)
Lung Neoplasms (Phase 1)
Mesothelioma (Phase 1)
Trials (1 total)
Trial APIs (1 total)